Top 10 Key Players companies in Intrauterine device by Most News Heat in the Switzerland in 2022 – Discovery

Free Trial

The Intrauterine device top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat Intrauterine device Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

An intrauterine device (IUD), also known as intrauterine contraceptive device (IUCD or ICD) or coil, is a small, often T-shaped birth control device that is inserted into a woman's uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). One study found that female family planning providers choose LARC methods more often (41.7%) than the general public (12.1%).Among birth control methods, IUDs, along with contraceptive implants, result in the greatest satisfaction among users.

Ranking Year:

Region:

Ranking:

1	Centre Hospitalier Universitaire Vaudois	Vaud, Switzerland	Drug marketing,Bionics,Blood cell, ...[+2]	news: 4
2	STARTUP Aspivix SA	Vaud, Switzerland	Medical equipment,Intrauterine device,Cervix, ...[+2]	news: 3
3	Novartis AG	Basel-Stadt, Switzerland	Dosage form,Health care,Medicine, ...[+2]	news: 2
4	Zürcher Kantonalbank	ZURICH, Switzerland	Monoclonal antibody,Biopharmaceutical,Private banking, ...[+2]	news: 2
5	4FO Ventures Partners	Switzerland	Alternative investment,Asset management	news: 2
6	Nestlé SA	Vaud, Switzerland	Ice cream,Nutrition,Cosmetics, ...[+2]	news: 1
7	International Olympic Committee	Vaud, Switzerland	Executive board,sports equipment,Conference management, ...[+1]	news: 1
8	Galderma Holding SA	Vaud, Switzerland	Aesthetics,Crisaborole,Medicine, ...[+2]	news: 1
9	Ferring Pharmaceuticals SA	Vaud, Switzerland	Hormone therapy,Biopharmaceutical,Gonadotropin, ...[+2]	news: 1
10	InnoSuisse	Bern, Switzerland	Pharmaceutics,Aptamer,Drug design, ...[+2]	news: 1